US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
FR2646438B1
(fr)
*
|
1989-03-20 |
2007-11-02 |
Pasteur Institut |
Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
|
DE69032809T2
(de)
*
|
1989-11-06 |
1999-07-08 |
Cell Genesys Inc |
Herstellung von Proteinen mittels homologer Rekombination
|
US5272071A
(en)
*
|
1989-12-22 |
1993-12-21 |
Applied Research Systems Ars Holding N.V. |
Method for the modification of the expression characteristics of an endogenous gene of a given cell line
|
EP0779362B2
(de)
*
|
1989-12-22 |
2012-06-13 |
Laboratoires Serono SA |
DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen
|
GB9028062D0
(en)
*
|
1990-12-24 |
1991-02-13 |
Agricultural & Food Res |
Production of transgenic animals
|
WO1992019255A1
(en)
*
|
1991-05-06 |
1992-11-12 |
Cell Genesys, Inc. |
Gene manipulation and expression using genomic elements
|
EP0587791B1
(de)
*
|
1991-05-31 |
2004-04-07 |
Genentech, Inc. |
Expressionsteigerung durch Gentargeting in endogene Retrovirus-ähnliche Sequenzen
|
WO1993004169A1
(en)
*
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
NZ245015A
(en)
*
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US5968502A
(en)
*
|
1991-11-05 |
1999-10-19 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6270989B1
(en)
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US5641670A
(en)
*
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US20020108136A1
(en)
*
|
1997-03-21 |
2002-08-08 |
Sri |
Transgenic animals produced by homologous sequence targeting
|
AU4401993A
(en)
*
|
1992-06-04 |
1993-12-30 |
Exemplar Corporation |
Insertion of heterologous dna outside of known chromosomal genes
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US5733753A
(en)
*
|
1992-12-22 |
1998-03-31 |
Novo Nordisk A/S |
Amplification of genomic DNA by site specific integration of a selectable marker construct
|
ATE247171T1
(de)
*
|
1993-04-21 |
2003-08-15 |
Univ Edinburgh |
Expression von heterologen genen nach einem ziel- expressionsprofil
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US6001968A
(en)
*
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
US5759775A
(en)
|
1994-10-27 |
1998-06-02 |
Genetech, Inc. |
Methods for detecting nucleic acids encoding AL--1 neurotrophic factor
|
US6610296B2
(en)
|
1995-10-26 |
2003-08-26 |
Genentech, Inc. |
Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin
|
CA2241564C
(en)
|
1996-01-08 |
2013-09-03 |
Genentech, Inc. |
Wsx receptor and ligands
|
US7148004B1
(en)
|
1997-01-16 |
2006-12-12 |
The Rockefeller University |
Oligonucleotides of the OB-R isoforms and methods of diagnosing body weight
|
US7063958B1
(en)
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
US7084252B1
(en)
|
1996-01-16 |
2006-08-01 |
The Rockefeller University |
DB, the receptor for leptin
|
US7619079B2
(en)
|
1996-02-14 |
2009-11-17 |
The Rockefeller University |
Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
|
US5792210A
(en)
*
|
1996-06-10 |
1998-08-11 |
Environmental Behavior Modification Inc. |
Electrical tongue stimulator and method for addiction treatment
|
JP2000517185A
(ja)
|
1996-08-29 |
2000-12-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
新規なメタロプロテアーゼファミリーkuz
|
US6566089B1
(en)
|
1996-09-04 |
2003-05-20 |
Tularik Inc. |
Cell-based drug screens for regulators of gene expression
|
US5958727A
(en)
*
|
1996-09-13 |
1999-09-28 |
Novo Nordisk Biotech, Inc |
Methods for modifying the production of a polypeptide
|
JPH10117771A
(ja)
*
|
1996-10-23 |
1998-05-12 |
Natl Food Res Inst |
冷凍生地耐性実用パン酵母
|
US5925544A
(en)
*
|
1996-11-18 |
1999-07-20 |
Novo Nordisk A/S |
Method of homologous recombination followed by in vivo selection of DNA amplification
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
AU743305C
(en)
|
1997-01-17 |
2006-03-30 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US7148054B2
(en)
*
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US6025157A
(en)
*
|
1997-02-18 |
2000-02-15 |
Genentech, Inc. |
Neurturin receptor
|
US6777196B2
(en)
|
1997-02-18 |
2004-08-17 |
Genentech, Inc. |
Neurturin receptor
|
US6372453B1
(en)
|
1997-02-18 |
2002-04-16 |
Genetech, Inc. |
Neurturin receptor
|
JP4128227B2
(ja)
|
1997-03-14 |
2008-07-30 |
バイオジェン・アイデック・インコーポレイテッド |
哺乳類細胞内の特定部位に相同組換えによって遺伝子を組み込む方法とそれを実施するためのベクター
|
US5948653A
(en)
|
1997-03-21 |
1999-09-07 |
Pati; Sushma |
Sequence alterations using homologous recombination
|
US6172211B1
(en)
|
1997-07-11 |
2001-01-09 |
Boehringer Ingelheim International Gmbh |
Nucleic acid encoding tag7 polypeptide
|
CN1151258C
(zh)
*
|
1997-07-23 |
2004-05-26 |
罗切诊断学有限公司 |
通过内源基因活化制备促红细胞生成素
|
PT1000154E
(pt)
|
1997-07-23 |
2007-03-30 |
Roche Diagnostics Gmbh |
Identificação de linhas celulares humanas para a produção de proteínas humanas por activação endógena de genes
|
WO1999005267A1
(de)
*
|
1997-07-23 |
1999-02-04 |
Roche Diagnostics Gmbh |
Identifizierung humaner zellinien zur produktion humaner proteine durch endogene genaktivierung
|
US6548296B1
(en)
|
1997-07-23 |
2003-04-15 |
Roche Diagnostics Gmbh |
Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
|
US6391633B1
(en)
|
1997-07-23 |
2002-05-21 |
Roche Diagnostics Gmbh |
Production of erythropoietin by endogenous gene activation
|
US6897066B1
(en)
|
1997-09-26 |
2005-05-24 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
AU750025B2
(en)
*
|
1997-09-26 |
2002-07-11 |
Athersys, Inc. |
Expression of endogenous genes by non-homologous recombination of a vector construct with cellular DNA
|
US6740503B1
(en)
|
1997-09-26 |
2004-05-25 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
ZA989497B
(en)
†
|
1997-10-20 |
2000-04-19 |
Roche Diagnostics Gmbh |
Positive-negative selection in homologous recombination.
|
KR100735651B1
(ko)
|
1997-11-28 |
2007-07-06 |
세로노 제네틱스 인스티튜트 에스.에이. |
클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
|
AU757930B2
(en)
*
|
1997-12-01 |
2003-03-13 |
Roche Diagnostics Gmbh |
Optimization of cells for endogenous gene activation
|
JPH11243944A
(ja)
*
|
1998-03-04 |
1999-09-14 |
Natl Food Res Inst |
製パン用乾燥耐性実用パン酵母
|
US6541623B1
(en)
|
1998-04-03 |
2003-04-01 |
Hyseq, Inc. |
Interleukin—1 receptor antagonist and uses thereof
|
US6337072B1
(en)
|
1998-04-03 |
2002-01-08 |
Hyseq, Inc. |
Interleukin-1 receptor antagonist and recombinant production thereof
|
US6426191B1
(en)
|
1998-04-03 |
2002-07-30 |
Hyseq, Inc. |
Assays involving an IL-1 receptor antagonist
|
US6294655B1
(en)
|
1998-04-03 |
2001-09-25 |
Hyseq, Inc. |
Anti-interleukin-1 receptor antagonist antibodies and uses thereof
|
WO2000005393A2
(en)
|
1998-07-21 |
2000-02-03 |
Cobra Therapeutics Limited |
A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
|
JP4486256B2
(ja)
*
|
1998-10-22 |
2010-06-23 |
ザ・ジェネラル・ホスピタル・コーポレイション |
副甲状腺ホルモン(PTH)および副甲状腺ホルモン関連ペプチド(PTHrP)の生物活性ペプチドおよびペプチド誘導体
|
US6773911B1
(en)
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
TW570977B
(en)
*
|
1998-12-07 |
2004-01-11 |
Li-Wei Hsu |
An expression system for producing recombinant human erythropoietin, method for purifying secreted human erythropoietin and uses thereof
|
DE19857609A1
(de)
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
ATE421976T1
(de)
|
1999-05-18 |
2009-02-15 |
Dyax Corp |
Fab fragmentbibliotheken und verfahren für deren verwendung
|
US6495360B1
(en)
*
|
1999-05-28 |
2002-12-17 |
Photogen, Inc. |
Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
|
US20050129669A1
(en)
*
|
1999-06-21 |
2005-06-16 |
Transkaryotic Therapies, Inc., A Massachusetts Corporation |
DNA construct for effecting homologous recombination and uses thereof
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
WO2001023521A2
(en)
*
|
1999-09-29 |
2001-04-05 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (pth)
|
ATE412670T1
(de)
|
1999-09-29 |
2008-11-15 |
Gen Hospital Corp |
Parathyroid hormon (pth) polypeptidderivate
|
AU1647501A
(en)
|
1999-12-10 |
2001-06-18 |
Cytos Biotechnology Ag |
Replicon based activation of endogenous genes
|
WO2001051646A2
(en)
*
|
2000-01-13 |
2001-07-19 |
Novozymes Biotech, Inc. |
Methods for producing a polypeptide using a crippled translational initiator sequence
|
EP2143796A3
(de)
|
2000-02-29 |
2010-03-17 |
Millennium Pharmaceuticals, Inc. |
1983-, 52881-, 2398-, 45449-, 50289- und 52872-G- Protein-gekoppelte Rezeptoren und Verwendungen davon
|
EP1714661A3
(de)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
|
US6686188B2
(en)
|
2000-05-26 |
2004-02-03 |
Amersham Plc |
Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
|
US6656700B2
(en)
|
2000-05-26 |
2003-12-02 |
Amersham Plc |
Isoforms of human pregnancy-associated protein-E
|
GB0018876D0
(en)
*
|
2000-08-01 |
2000-09-20 |
Applied Research Systems |
Method of producing polypeptides
|
NZ524523A
(en)
*
|
2000-08-03 |
2006-02-24 |
Therapeutic Human Polyclonals |
Production of humanized antibodies in transgenic animals
|
US6803211B2
(en)
|
2000-08-25 |
2004-10-12 |
Pfizer Inc. |
Methods and compositions for diagnosing and treating disorders involving angiogenesis
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
KR100915482B1
(ko)
|
2000-12-06 |
2009-09-03 |
하리리 로버트 제이 |
태반 줄기 세포의 회수 방법
|
DE60144439D1
(de)
|
2000-12-20 |
2011-05-26 |
Hoffmann La Roche |
Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
|
MXPA03005406A
(es)
*
|
2000-12-20 |
2003-09-25 |
Hoffmann La Roche |
Conjugados de eritropoyetina.
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
EP2316919B1
(de)
|
2001-02-14 |
2015-10-07 |
Anthrogenesis Corporation |
Post-partum Säugetier-Plazenta, deren Verwendung und daraus gewonnene Stammzellen
|
MX348185B
(es)
|
2001-02-14 |
2017-06-02 |
Anthrogenesis Corp |
Placenta de mamíferos postparto, su uso y células madres placentales extraídas de ella.
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
EP1925671A1
(de)
|
2001-06-06 |
2008-05-28 |
Bioriginal Food & Science Corp. |
Flax-(Linum usitatissimum L.)-Samenspezifische Promotoren
|
EP2184359B1
(de)
|
2001-06-06 |
2016-03-02 |
Bioriginal Food & Science Corp. |
Samen-spezifische Promotoren aus Flachs (Linum usitatissimum L.)
|
WO2003009804A2
(en)
*
|
2001-07-23 |
2003-02-06 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (pth) analogs
|
US20030211040A1
(en)
|
2001-08-31 |
2003-11-13 |
Paul Greengard |
Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
EP2436393A1
(de)
|
2001-12-19 |
2012-04-04 |
Millennium Pharmaceuticals, Inc. |
Humane Diacylglycerol acyltransferase 2 - (DGAT2-) Familienmitglieder und Verwendungen davon
|
WO2003054172A2
(en)
*
|
2002-01-17 |
2003-07-03 |
Lonza Biologics Plc. |
Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
|
EP2301343A1
(de)
|
2002-02-13 |
2011-03-30 |
Anthrogenesis Corporation |
Embryoartige Stammzellen aus der Post Partum Plazenta von Säugetieren sowie Anwendungszwecke und Behandlungsverfahren, bei denen diese Zellen verwendet werden
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
WO2003094841A2
(en)
*
|
2002-05-06 |
2003-11-20 |
Functional Genetics, Inc. |
Mammalian genes involed in rapamycin resistance and tumorgenesis: annexin xiii genes
|
US7205398B2
(en)
|
2002-05-24 |
2007-04-17 |
Schering-Plough Animal Health Corporation |
Eta-1 gene and methods for use
|
AU2003268135A1
(en)
*
|
2002-08-15 |
2004-03-19 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
|
WO2004020581A2
(en)
*
|
2002-08-15 |
2004-03-11 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
WO2004047757A2
(en)
|
2002-11-21 |
2004-06-10 |
University Of Massachusets |
Diagnosing and treating hematopoietic cancers
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
JP2006509770A
(ja)
|
2002-11-26 |
2006-03-23 |
アンソロジェネシス コーポレーション |
細胞治療学、細胞治療単位、およびそれらを利用した治療法
|
US20050048041A1
(en)
*
|
2003-01-13 |
2005-03-03 |
Rao Mahendra S. |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
AU2004204509A1
(en)
*
|
2003-01-13 |
2004-07-29 |
Mario R. Capecchi |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
WO2004064785A2
(en)
|
2003-01-14 |
2004-08-05 |
Dana Farber Cancer Institute |
Cancer therapy sensitizer
|
WO2004071462A2
(en)
|
2003-02-12 |
2004-08-26 |
Johns Hopkins University |
Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction
|
WO2004093902A1
(en)
*
|
2003-03-19 |
2004-11-04 |
The General Hospital Corporation |
CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH α-HELIX STABILIZERS
|
WO2005009358A2
(en)
|
2003-07-17 |
2005-02-03 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (pth) analogs
|
US7287952B2
(en)
*
|
2003-07-23 |
2007-10-30 |
Lockheed Martin Corporation |
Feeder load automation system and method of use
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
CN1897959A
(zh)
|
2003-09-29 |
2007-01-17 |
沃伦药品公司 |
用于治疗和预防脓毒病和粘连形成的组织保护细胞因子
|
BRPI0416141B8
(pt)
|
2003-11-01 |
2021-05-25 |
Biovation Ltd |
anticorpo anti-cd52 modificado, composição farmacêutica, vetores de expressão, e método para preparar uma imunoglobulina
|
ES2460671T3
(es)
*
|
2003-12-19 |
2014-05-14 |
F. Hoffmann-La Roche Ag |
Uso de eritropoyetina en el tratamiento de alteraciones de la distribución del hierro en enfermedades intestinales inflamatorias crónicas
|
DK1709161T3
(da)
*
|
2004-01-19 |
2009-01-26 |
Nsgene As |
Humane terapeutiske celler, som udskiller nervevækstfaktor
|
US7510858B2
(en)
|
2004-08-02 |
2009-03-31 |
Janssen Pharmaceutica N.V. |
IRAK 1c splice variant and its use
|
US7893197B2
(en)
|
2004-08-25 |
2011-02-22 |
Janssen Pharmaceutica N.V. |
Relaxin-3 chimeric polypeptides and their preparation and use
|
JP2008511678A
(ja)
|
2004-09-02 |
2008-04-17 |
イェール ユニバーシティ |
マイクロrnaによるオンコジーンの調節
|
CA3079874C
(en)
|
2004-10-22 |
2023-01-03 |
Revivicor, Inc. |
Ungulates with genetically modified immune systems
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
EP1844068A4
(de)
*
|
2005-01-25 |
2009-09-30 |
Apollo Life Sciences Ltd |
Moleküle und chimere moleküle davon
|
EP2365086A1
(de)
|
2005-02-09 |
2011-09-14 |
Bioriginal Food & Science Corporation |
Neuartige Omega-3-Fettsäure-Desaturase-Familienmitglieder und Verwendungen davon
|
WO2006121560A2
(en)
|
2005-04-06 |
2006-11-16 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for treatment of cns disorders
|
US8354384B2
(en)
|
2005-06-23 |
2013-01-15 |
Yale University |
Anti-aging micrornas
|
NZ597304A
(en)
|
2005-10-13 |
2013-06-28 |
Anthrogenesis Corp |
Immunomodulation using placental stem cells
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
US8014957B2
(en)
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
EP1976977B1
(de)
|
2005-12-29 |
2015-07-08 |
Anthrogenesis Corporation |
Stammzell-populationen aus der plazenta
|
ZA200804718B
(en)
|
2005-12-29 |
2010-04-28 |
Anthrogenesis Corp |
Co-culture of placental stem cells and stem cells from a second source
|
DE102006004008A1
(de)
|
2006-01-27 |
2007-08-02 |
Hannelore Prof. Dr. Dr. Ehrenreich |
Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose
|
LT2004683T
(lt)
|
2006-03-24 |
2016-10-10 |
Biogen Hemophilia Inc. |
Pc5, kaip faktoriaus ix pro-peptidą apdorojantis fermentas
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
AU2007257162A1
(en)
|
2006-06-05 |
2007-12-13 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008019062A2
(en)
*
|
2006-08-04 |
2008-02-14 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (pth)
|
EP2054074B8
(de)
|
2006-08-04 |
2014-11-12 |
Prolong Pharmaceuticals, LLC |
Modifiziertes erythropoietin
|
PE20081216A1
(es)
|
2006-09-01 |
2008-09-04 |
Therapeutic Human Polyclonals Inc |
Expresion mejorada de la inmunoglobulina humana o humanizada en animales transgenicos no humanos
|
US8562972B2
(en)
|
2006-10-23 |
2013-10-22 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
US7745148B2
(en)
|
2006-10-30 |
2010-06-29 |
Functional Genetics, Inc. |
Random homozygous gene perturbation to enhance antibody production
|
CN101657206B
(zh)
|
2007-02-12 |
2013-07-03 |
人类起源公司 |
利用胎盘干细胞治疗炎性疾病
|
EP2243834A1
(de)
|
2007-03-05 |
2010-10-27 |
Cancer Care Ontario |
Abschätzung des Kolorektalkarzinomrisikos
|
CA2687079A1
(en)
|
2007-05-11 |
2008-11-20 |
The Trustees Of The University Of Pennsylvania |
Methods of treatment of skin ulcers
|
KR101730290B1
(ko)
|
2007-05-11 |
2017-04-25 |
토마스 제퍼슨 유니버시티 |
신경변성 질환 및 장애의 치료 및 예방 방법
|
US20090010966A1
(en)
|
2007-06-21 |
2009-01-08 |
Angelica Therapeutics, Inc. |
Modified diphtheria toxins
|
AR067536A1
(es)
|
2007-07-17 |
2009-10-14 |
Hoffmann La Roche |
Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
|
CL2008002053A1
(es)
|
2007-07-17 |
2009-05-22 |
Hoffmann La Roche |
Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
|
WO2009010107A1
(en)
|
2007-07-19 |
2009-01-22 |
Hannelore Ehrenreich |
Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
|
US8568737B2
(en)
|
2007-08-01 |
2013-10-29 |
The General Hospital Corporation |
Screening methods using G-protein coupled receptors and related compositions
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
EP2205625B1
(de)
|
2007-09-24 |
2012-09-12 |
Cornell University |
Immunogene proteine aus der genomabgeleiteten äusseren membran von leptospira und darauf basierende zusammensetzungen und verfahren
|
CN101878034B
(zh)
|
2007-09-28 |
2013-11-20 |
细胞基因细胞疗法公司 |
使用人胎盘灌洗液和人来自胎盘的中间体自然杀伤细胞的肿瘤抑制
|
US8501449B2
(en)
|
2007-12-04 |
2013-08-06 |
Proteon Therapeutics, Inc. |
Recombinant elastase proteins and methods of manufacturing and use thereof
|
WO2009089120A2
(en)
|
2008-01-02 |
2009-07-16 |
Suregene Llc |
Genetic markers of mental illness
|
AU2009205920A1
(en)
|
2008-01-17 |
2009-07-23 |
Suregene Llc |
Genetic markers of mental illness
|
EP2257626A2
(de)
*
|
2008-03-01 |
2010-12-08 |
Abraxis BioScience, LLC |
Behandlung, diagnostikum und verfahren zur entdeckung eines antagonisten unter verwendung sparc-spezifischer mirnas
|
JP5670755B2
(ja)
|
2008-03-12 |
2015-02-18 |
ザ ロックフェラー ユニバーシティ |
翻訳プロファイリング及び分子表現型解析のための方法及び組成物
|
CA2723716A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Abraxis Bioscience, Llc |
Enhancement of drug therapy by mirna
|
KR20200011604A
(ko)
|
2008-08-20 |
2020-02-03 |
안트로제네시스 코포레이션 |
개선된 세포 조성물 및 그의 제조 방법
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
EP2344672B8
(de)
|
2008-09-25 |
2014-12-24 |
SureGene LLC |
Genetische marker zur optimierung einer schizophreniebehandlung
|
DK2342226T3
(en)
|
2008-09-26 |
2016-09-26 |
Dana Farber Cancer Inst Inc |
HUMAN ANTI-PD-1, PD-L1 AND PD-L2 ANTIBODIES AND APPLICATIONS THEREOF
|
US8110185B2
(en)
|
2008-10-03 |
2012-02-07 |
St. Michael's Hospital |
Method for preventing and treating cardiovascular diseases with BRCA1
|
US20100120063A1
(en)
*
|
2008-10-10 |
2010-05-13 |
Discoverx Corporation |
GPCR Arrestin Assays
|
WO2010051288A1
(en)
|
2008-10-27 |
2010-05-06 |
Revivicor, Inc. |
Immunocompromised ungulates
|
CA2742710A1
(en)
|
2008-11-04 |
2010-05-14 |
Janssen Pharmaceutica Nv |
Crhr2 peptide agonists and uses thereof
|
US8367409B2
(en)
|
2008-11-19 |
2013-02-05 |
Anthrogenesis Corporation |
Amnion derived adherent cells
|
US8492133B2
(en)
|
2009-01-20 |
2013-07-23 |
Ramot At Tel Aviv University, Ltd. |
MIR-21 promoter driven targeted cancer therapy
|
WO2010088522A2
(en)
|
2009-01-30 |
2010-08-05 |
Ab Biosciences, Inc. |
Novel lowered affinity antibodies and uses therefor
|
US8211655B2
(en)
*
|
2009-02-12 |
2012-07-03 |
Discoverx Corporation |
Wild-type receptor assays
|
US20110105397A1
(en)
|
2009-11-04 |
2011-05-05 |
Gengo Peter J |
Method for treating heart failure with stresscopin-like peptides
|
CA2778953C
(en)
|
2009-11-13 |
2020-01-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
|
EP3037435B1
(de)
|
2009-11-17 |
2019-08-07 |
MUSC Foundation for Research Development |
Humane monoklonale antikörper gegen menschliches nukleolin
|
ES2577017T3
(es)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedimientos y kits para identificar la aneuploidia
|
CN102822330A
(zh)
|
2010-01-26 |
2012-12-12 |
人类起源公司 |
使用胎盘干细胞对骨相关癌的治疗
|
JP6101489B2
(ja)
|
2010-01-28 |
2017-03-22 |
アブ バイオサイエンシズ インコーポレイテッド |
親和性が低下した抗体およびそれを作製する方法
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
CN107098958B
(zh)
|
2010-03-26 |
2021-11-05 |
达特茅斯大学理事会 |
Vista调节性t细胞介体蛋白、vista结合剂及其用途
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
SI2556145T1
(sl)
|
2010-04-07 |
2017-01-31 |
Anthrogenesis Corporation |
Angiogeneza z uporabo placentnih matičnih celic
|
JP5941040B2
(ja)
|
2010-05-13 |
2016-06-29 |
ザ ジェネラル ホスピタル コーポレイション |
副甲状腺ホルモン類似体およびその使用
|
WO2012009422A1
(en)
|
2010-07-13 |
2012-01-19 |
Anthrogenesis Corporation |
Methods of generating natural killer cells
|
EP2601609B1
(de)
|
2010-08-02 |
2017-05-17 |
Population Bio, Inc. |
Zusammensetzungen und verfahren zur erkennung der verursachenden mutationen in genetischen erkrankungen
|
PL2616101T3
(pl)
|
2010-09-14 |
2015-01-30 |
Hoffmann La Roche |
Sposób oczyszczania pegylowanej erytropoetyny
|
JP2014504184A
(ja)
|
2010-12-01 |
2014-02-20 |
スパイナル・モデュレーション・インコーポレイテッド |
神経構造への薬剤の直接送達
|
EP2471543A1
(de)
|
2010-12-02 |
2012-07-04 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Toleranzinduktion oder Immunsuppression zur Verhinderung von insbesondere Transplantat-Wirt-Reaktion (GvHD) durch kurzzeitige Vorinkubation von transplantierten Zellsuspensionen, Geweben oder Organen, die mit Liganden zu Zelloberflächenmolekülen beschichtet sind
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
CN113559126A
(zh)
|
2011-06-01 |
2021-10-29 |
人类起源公司 |
利用胎盘干细胞治疗疼痛
|
US8759313B2
(en)
|
2011-08-03 |
2014-06-24 |
The Charlotte-Mecklenburg Hospital Authority |
Treatment of fibrosis using microRNA 19b
|
WO2013003697A1
(en)
|
2011-06-30 |
2013-01-03 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
US10221454B2
(en)
|
2011-10-10 |
2019-03-05 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
US11180807B2
(en)
|
2011-11-04 |
2021-11-23 |
Population Bio, Inc. |
Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
|
DK2812452T3
(da)
|
2012-02-09 |
2020-06-29 |
Population Bio Inc |
Fremgangsmåder og sammensætninger til screening og behandling af udviklingsforstyrrelser
|
LT2814844T
(lt)
|
2012-02-15 |
2017-10-25 |
Novo Nordisk A/S |
Antikūnai, kurie jungiasi ir blokuoja ekspresuotą ant mieloidinių ląstelių inicijuojantį receptorių 1 (trem-1)
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
RS57827B1
(sr)
|
2012-02-15 |
2018-12-31 |
Novo Nordisk As |
Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
|
EP4155401A1
(de)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
WO2013152011A1
(en)
|
2012-04-02 |
2013-10-10 |
Ab Biosciences, Inc. |
Novel human control antibodies and uses therefor
|
WO2013158309A2
(en)
*
|
2012-04-18 |
2013-10-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-disruptive gene targeting
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
CA2884704C
(en)
|
2012-09-07 |
2023-04-04 |
Randolph J. Noelle |
Vista modulators for diagnosis and treatment of cancer
|
EP2895621B1
(de)
|
2012-09-14 |
2020-10-21 |
Population Bio, Inc. |
Verfahren und zusammensetzungen zur diagnose, prognose und behandlung neurologischer erkrankungen
|
US10233495B2
(en)
|
2012-09-27 |
2019-03-19 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
CN103864913A
(zh)
|
2012-12-18 |
2014-06-18 |
联亚生技开发股份有限公司 |
重组蛋白
|
EP3622960A1
(de)
|
2013-02-05 |
2020-03-18 |
Celularity, Inc. |
Natürliche killerzellen aus plazenta
|
EP2971100A1
(de)
|
2013-03-13 |
2016-01-20 |
Sequenom, Inc. |
Primer zur analyse der dna-methylierung
|
US10059750B2
(en)
|
2013-03-15 |
2018-08-28 |
Angelica Therapeutics, Inc. |
Modified toxins
|
WO2014138921A1
(en)
|
2013-03-15 |
2014-09-18 |
Apotex Inc. |
Enhanced liquid formulation stability of erythropoietin alpha through purification processing
|
US10294295B2
(en)
|
2013-11-27 |
2019-05-21 |
Inis Biotech Llc |
Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment
|
MX369173B
(es)
|
2013-12-24 |
2019-10-30 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista.
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
US11365447B2
(en)
|
2014-03-13 |
2022-06-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
WO2015143177A1
(en)
|
2014-03-21 |
2015-09-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Genome editing without nucleases
|
CN107073109B
(zh)
|
2014-06-11 |
2021-08-06 |
凯西·A·格林 |
Vista激动剂和拮抗剂抑制或增强体液免疫的用途
|
GB2558326B
(en)
|
2014-09-05 |
2021-01-20 |
Population Bio Inc |
Methods and compositions for inhibiting and treating neurological conditions
|
KR102473092B1
(ko)
|
2014-09-15 |
2022-12-01 |
칠드런'즈 메디컬 센터 코포레이션 |
히스톤 h3-리신 트리메틸화를 제거함으로써 체세포 핵 이식(scnt) 효율을 증가시키는 방법 및 조성물
|
EP3015475A1
(de)
|
2014-10-31 |
2016-05-04 |
Novartis AG |
Säugetierzellen zur Expression von Cytomegalovirus-Antigenen
|
WO2016090347A1
(en)
|
2014-12-05 |
2016-06-09 |
Immunext, Inc. |
Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
|
EP3031822A1
(de)
|
2014-12-08 |
2016-06-15 |
Novartis AG |
Cytomegalovirus-Antigene
|
EP3048114A1
(de)
|
2015-01-22 |
2016-07-27 |
Novartis AG |
Cytomegalovirus-Antigene und Verwendungen davon
|
WO2016118832A1
(en)
|
2015-01-22 |
2016-07-28 |
University Of Massachusetts |
Cancer immunotherapy
|
EP3047856A1
(de)
|
2015-01-23 |
2016-07-27 |
Novartis AG |
Cmv-antigene und ihre verwendungen
|
BR112017027870A2
(pt)
|
2015-06-24 |
2018-08-28 |
Janssen Pharmaceutica Nv |
anticorpos e fragmentos anti-vista
|
BR112018016461A2
(pt)
|
2016-02-12 |
2019-10-01 |
Janssen Pharmaceutica Nv |
anticorpos e fragmentos anti-vista, usos dos mesmos e métodos de identificação dos mesmos
|
EP3426691A4
(de)
|
2016-03-07 |
2019-09-25 |
Charlestonpharma, LLC |
Anti-nukleolin-antikörper
|
MX2018012469A
(es)
|
2016-04-15 |
2019-07-04 |
Immunext Inc |
Anticuerpos vista antihumanos y uso de los mismos.
|
CN109415427A
(zh)
|
2016-07-15 |
2019-03-01 |
豪夫迈·罗氏有限公司 |
用于纯化聚乙二醇化的促红细胞生成素的方法
|
US10766798B2
(en)
*
|
2017-02-02 |
2020-09-08 |
Massachusetts Institute Of Technology |
Engineered yeast as a method for bioremediation
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
JP7227633B2
(ja)
|
2017-12-29 |
2023-02-22 |
エフ. ホフマン-ラ ロシュ エージー. |
Peg化タンパク質組成物を提供するための方法
|
US11518781B2
(en)
|
2017-12-29 |
2022-12-06 |
Hoffmann-La Roche Inc. |
Process for providing PEGylated protein composition
|
JP7137625B2
(ja)
|
2017-12-29 |
2022-09-14 |
エフ.ホフマン-ラ ロシュ アーゲー |
Peg化タンパク質組成物を提供するための方法
|
HRP20221504T1
(hr)
|
2018-08-08 |
2023-03-31 |
Pml Screening, Llc |
Postupci procjene rizika od razvoja progresivne multifokalne leukoencefalopatije uzrokovane john cunningham virusom pomoću genetskog testiranja
|
EP4004018A1
(de)
|
2019-07-24 |
2022-06-01 |
GlaxoSmithKline Biologicals SA |
Modifizierte humane cytomegalovirus-proteine
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
WO2023144665A1
(en)
|
2022-01-28 |
2023-08-03 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|
WO2024129459A1
(en)
|
2022-12-16 |
2024-06-20 |
University Of Rochester |
Repairmen! of barrier dysfunction in esophagus
|